Fate Therapeutics rises on Lupus drug data

Fate Therapeutics (FATE) closes 12% higher after soaring 73% on drug data (update). (00:25) Super Micro (SMCI) announces appointment of independent auditor, filing of compliance plan with Nasdaq. (02:11) Blackstone (BX) is said to near acquisition of Jersey Mike's sandwich chain. (03:02)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers Tuesday: SMCI, INCY, and moreNippon Steel makes anti-import promise to win worker support for US Steel dealNo time to chill: Netflix must fix livestreaming before Christmas NFL games or lose faceDOJ to ask judge to push Google to sell Chrome browser - BloombergApple said to offer $100M investment in Indonesia to reverse iPhone 16 banSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.